Skip to main content
Top

Breast Cancer Research and Treatment

Issue 3/2011

Content (39 Articles)

Review

HER2 discordance between primary breast cancer and its paired metastasis: tumor biology or test artefact? Insights through meta-analysis

Nehmat Houssami, Petra Macaskill, Rosemary L. Balleine, Michael Bilous, Mark D. Pegram

Preclinical study

Local anesthetics inhibit kinesin motility and microtentacle protrusions in human epithelial and breast tumor cells

Jennifer R. Yoon, Rebecca A. Whipple, Eric M. Balzer, Edward H. Cho, Michael A. Matrone, Michelle Peckham, Stuart S. Martin

Preclinical study

Multicentric breast cancer: clonality and prognostic studies

R. Eeles, G. Knee, S. Jhavar, J. Mangion, S. Ebbs, G. Gui, S. Thomas, M. Coppen, R. A’Hern, S. Gray, C. Cooper, J. Bartek, J. Yarnold

Preclinical study

Increased SIAH expression predicts ductal carcinoma in situ (DCIS) progression to invasive carcinoma

Kathryn C. Behling, Amy Tang, Boris Freydin, Inna Chervoneva, Sameep Kadakia, Gordon F. Schwartz, Hallgeir Rui, Agnieszka K. Witkiewicz

Preclinical study

Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma

Hermien Hartog, Hugo M. Horlings, Bert van der Vegt, Bas Kreike, Abderrahim Ajouaou, Marc J. van de Vijver, H. Marike Boezen, Geertruida H. de Bock, Winette T. A. van der Graaf, Jelle Wesseling

Preclinical study

SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancer

Kathryn A. Clausen, Kimberly R. Blish, Charles E. Birse, Matthew A. Triplette, Timothy E. Kute, Gregory B. Russell, Ralph B. D’Agostino Jr., Lance D. Miller, Frank M. Torti, Suzy V. Torti

Preclinical study

High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer

Ida Johansson, Cecilia Nilsson, Pontus Berglund, Carina Strand, Göran Jönsson, Johan Staaf, Markus Ringnér, Heli Nevanlinna, Rosa B. Barkardottir, Åke Borg, Håkan Olsson, Lena Luts, Marie-Louise Fjällskog, Ingrid Hedenfalk

Preclinical study

Acquisition of metastatic tissue from patients with bone metastases from breast cancer

J. F. Hilton, E. Amir, S. Hopkins, M. Nabavi, G. DiPrimio, A. Sheikh, S. J. Done, D. Gianfelice, F. Kanji, S. Dent, D. Barth, N. Bouganim, A. Al-Najjar, M. Clemons

Preclinical study

Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAs

A. Smeets, A. Daemen, I. Vanden Bempt, O. Gevaert, B. Claes, H. Wildiers, R. Drijkoningen, P. Van Hummelen, D. Lambrechts, B. De Moor, P. Neven, C. Sotiriou, T. Vandorpe, R. Paridaens, M. R. Christiaens

Preclinical study

Estrogen receptor β causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A, and BTG2

Sreenivasan Paruthiyil, Aleksandra Cvoro, Mary Tagliaferri, Isaac Cohen, Emma Shtivelman, Dale C. Leitman

Clinical Trial

Drug switch because of treatment-related adverse side effects in endocrine adjuvant breast cancer therapy: how often and how often does it work?

Uwe Güth, Mary Elizabeth Myrick, Andreas Schötzau, Nerbil Kilic, Seraina Margaretha Schmid

Clinical Trial

Leptomeningeal metastases from breast cancer: intrinsic subtypes may affect unique clinical manifestations

Soohyeon Lee, Hee Kyung Ahn, Yeon Hee Park, Do Hyun Nam, Jung Il Lee, Won Park, Doo Ho Choi, Seung Jae Huh, Kyung Tae Park, Jin Seok Ahn, Young-Hyuck Im

Clinical trial

A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer

Suleiman Massarweh, Yee L. Tham, Jian Huang, Krystal Sexton, Heidi Weiss, Anna Tsimelzon, Amanda Beyer, Mothaffar Rimawi, Wei Yen Cai, Susan Hilsenbeck, Suzanne Fuqua, Richard Elledge

Clinical trial

First-line bevacizumab in combination with weekly paclitaxel for metastatic breast cancer: efficacy and safety results from a large, open-label, single-arm Japanese study

Kenjiro Aogi, Norikazu Masuda, Shinji Ohno, Takashi Oda, Hiroji Iwata, Masahiro Kashiwaba, Yasuhiro Fujiwara, Shunji Kamigaki, Yoshinori Ito, Takayuki Ueno, Shigemitsu Takashima

Clinical Trial

The role of topoisomerase IIα in predicting sensitivity to anthracyclines in breast cancer patients: a meta-analysis of published literatures

Yueyao Du, Qiong Zhou, Wenjin Yin, Liheng Zhou, Genhong Di, Zhenzhou Shen, Zhimin Shao, Jinsong Lu

Clinical Trial

Oncological and cosmetic outcome in breast cancer patients undergoing “moving window” operation

Masakuni Noguchi, Masafumi Inokuchi, Yukako Ohno, Miki Yokoi-Noguchi, Yasuharu Nakano, Takeo Kosaka

Clinical trial

Excised and irradiated volumes in relation to the tumor size in breast-conserving therapy

M. D. den Hartogh, B. van Asselen, E. M. Monninkhof, M. A. A. J. van den Bosch, M. van Vulpen, P. J. van Diest, K. G. A. Gilhuijs, A. J. Witkamp, L. van de Bunt, W. P. T. M. Mali, H. J. G. D. van den Bongard

Clinical Trial

Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation

Emilia Montagna, Vincenzo Bagnardi, Nicole Rotmensz, Giuseppe Viale, Giuseppe Cancello, Manuelita Mazza, Anna Cardillo, Raffaella Ghisini, Viviana Galimberti, Paolo Veronesi, Simonetta Monti, Alberto Luini, Paola Rafaniello Raviele, Mauro Giuseppe Mastropasqua, Aron Goldhirsch, Marco Colleoni

Epidemiology

The association between chronic disease burden and quality of life among breast cancer survivors in Missouri

Anjali D. Deshpande, Julianne A. Sefko, Donna B. Jeffe, Mario Schootman

Epidemiology

Genetic variation in proinflammatory cytokines IL6, IL6R, TNF-region, and TNFRSF1A and risk of breast cancer

Margaret M. Madeleine, Lisa G. Johnson, Mari Malkki, Alexa J. Resler, Effie W. Petersdorf, Barbara McKnight, Kathleen E. Malone

Epidemiology

Genetic variants of 6q25 and breast cancer susceptibility: a two-stage fine mapping study in a Chinese population

Jing Han, Tao Jiang, Hongling Bai, Hongru Gu, Jing Dong, Hongxia Ma, Zhibin Hu, Hongbing Shen

Epidemiology

The effect of system-level access factors on receipt of reconstruction among Latina and white women with DCIS

Celia Patricia Kaplan, Leah S. Karliner, E. Shelley Hwang, Joan Bloom, Susan Stewart, Dana Nickleach, Jessica Quinn, Angela Thrasher, Anna Maria Nápoles

Epidemiology

Well-done meat intake and meat-derived mutagen exposures in relation to breast cancer risk: the Nashville Breast Health Study

Zhenming Fu, Sandra L. Deming, Alecia M. Fair, Martha J. Shrubsole, Debra M. Wujcik, Xiao-Ou Shu, Mark Kelley, Wei Zheng

Epidemiology

Second events following ductal carcinoma in situ of the breast: a register-based cohort study

Ragnhild Sørum Falk, Solveig Hofvind, Per Skaane, Tor Haldorsen

Epidemiology

A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families

Atocha Romero, Pedro Pérez-Segura, Alicia Tosar, José Ángel García-Saenz, Eduardo Díaz-Rubio, Trinidad Caldés, Miguel de la Hoya

Epidemiology

Evidence for a link between TNFRSF11A and risk of breast cancer

Núria Bonifaci, Marta Palafox, Pasquale Pellegrini, Ana Osorio, Javier Benítez, Paolo Peterlongo, Siranoush Manoukian, Bernard Peissel, Daniela Zaffaroni, Gaia Roversi, Monica Barile, Alessandra Viel, Frederique Mariette, Loris Bernard, Paolo Radice, Bella Kaufman, Yael Laitman, Roni Milgrom, Eitan Friedman, María E. Sáez, Fina Climent, María Teresa Soler, Orland Diez, Judith Balmaña, Adriana Lasa, Teresa Ramón y Cajal, María-Dolores Miramar, Miguel de la Hoya, Pedro Pérez-Segura, Trinidad Caldés, Víctor Moreno, Ander Urruticoechea, Joan Brunet, Conxi Lázaro, Ignacio Blanco, Miguel Angel Pujana, Eva González-Suárez

Epidemiology

Patient and tumor characteristics of bilateral breast cancer at screening mammography in the Netherlands, a population-based study

Wikke Setz-Pels, Lucien E. M. Duijm, Johanna H. Groenewoud, Marieke W. J. Louwman, Frits H. Jansen, Mike van Beek, Menno L. Plaisier, Adri C. Voogd

Epidemiology

Second primary breast, endometrial, and ovarian cancers in Black and White breast cancer survivors over a 35-year time span: effect of age

Hala H. Nsouli-Maktabi, Donald E. Henson, Naji Younes, Heather A. Young, Sean D. Cleary

Brief Report

Characterisation of unclassified variants in the BRCA1/2 genes with a putative effect on splicing

Rita Dias Brandão, Kees van Roozendaal, Demis Tserpelis, Encarna Gómez García, Marinus J. Blok

Brief Report

MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism

Muhua Yang, Yuan Yao, Gabriel Eades, Yongshu Zhang, Qun Zhou

Brief Report

The earwax-associated SNP c.538G>A (G180R) in ABCC11 is not associated with breast cancer risk in Europeans

Thomas Lang, Christina Justenhoven, Stefan Winter, Christian Baisch, Ute Hamann, Volker Harth, Yon-Dschun Ko, Sylvia Rabstein, Anne Spickenheuer, Beate Pesch, Thomas Brüning, Matthias Schwab, Hiltrud Brauch

Letter to the Editor

Data in a recent meta-analysis about TNF-alpha polymorphisms and breast cancer susceptibility need for clarification

Min-Bin Chen, Jin-Hua Gu, Xiao-Yang Wu, Pei-Hua Lu, Rong-Min Gu

Letter to the Editor

RAD51C germline mutations in Chinese women with familial breast cancer

Zhiyuan Pang, Lu Yao, Juan Zhang, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, Yuntao Xie

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine